Pro Share Advisors LLC Novo Cure LTD Transaction History

Pro Share Advisors LLC

  • $46.4 Billion
  • Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Pro Share Advisors LLC holds 21,357 shares of NVCR stock, worth $241,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,357
Previous 24,998 14.57%
Holding current value
$241,761
Previous $444,000 38.06%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025
SELL
$10.9 - $18.46 $39,686 - $67,212
-3,641 Reduced 14.57%
21,357 $275,000
Q2 2025

Aug 07, 2025
SELL
$15.37 - $19.4 $46,340 - $58,490
-3,015 Reduced 10.76%
24,998 $444,000
Q1 2025

May 08, 2025
SELL
$17.82 - $30.19 $126,557 - $214,409
-7,102 Reduced 20.22%
28,013 $499,000
Q4 2024

Feb 13, 2025
BUY
$14.54 - $33.41 $124,985 - $287,192
8,596 Added 32.41%
35,115 $1.05 Million
Q3 2024

Nov 13, 2024
BUY
$15.61 - $23.34 $413,961 - $618,953
26,519 New
26,519 $414,000
Q2 2023

Aug 10, 2023
SELL
$40.29 - $82.51 $17,687 - $36,221
-439 Reduced 6.0%
6,872 $285,000
Q1 2023

May 25, 2023
BUY
$56.44 - $118.81 $412,632 - $868,619
7,311 New
7,311 $439,000
Q4 2022

Feb 02, 2023
SELL
$63.98 - $85.37 $12,476 - $16,647
-195 Reduced 1.9%
10,049 $737,000
Q3 2022

Nov 04, 2022
BUY
$67.99 - $89.57 $42,493 - $55,981
625 Added 6.5%
10,244 $778,000
Q2 2022

Aug 01, 2022
SELL
$56.6 - $89.9 $182,648 - $290,107
-3,227 Reduced 25.12%
9,619 $668,000
Q1 2022

May 10, 2022
SELL
$60.15 - $84.52 $241,622 - $339,516
-4,017 Reduced 23.82%
12,846 $1.06 Million
Q4 2021

Feb 08, 2022
BUY
$75.08 - $121.99 $1.11 Million - $1.8 Million
14,755 Added 699.95%
16,863 $1.27 Million
Q3 2021

Nov 12, 2021
SELL
$116.17 - $194.55 $115,589 - $193,577
-995 Reduced 32.07%
2,108 $245,000
Q2 2021

Aug 13, 2021
BUY
$130.4 - $225.58 $196,382 - $339,723
1,506 Added 94.3%
3,103 $688,000
Q1 2021

May 14, 2021
BUY
$124.11 - $190.17 $9,804 - $15,023
79 Added 5.2%
1,597 $211,000
Q4 2020

Feb 09, 2021
SELL
$112.16 - $174.14 $1.82 Million - $2.82 Million
-16,215 Reduced 91.44%
1,518 $263,000
Q3 2020

Nov 13, 2020
BUY
$58.05 - $111.31 $97,698 - $187,334
1,683 Added 10.49%
17,733 $1.97 Million
Q2 2020

Aug 03, 2020
SELL
$57.2 - $74.41 $151,808 - $197,484
-2,654 Reduced 14.19%
16,050 $952,000
Q1 2020

May 15, 2020
SELL
$57.05 - $95.75 $825,798 - $1.39 Million
-14,475 Reduced 43.63%
18,704 $1.26 Million
Q4 2019

Feb 12, 2020
SELL
$68.3 - $93.8 $224,911 - $308,883
-3,293 Reduced 9.03%
33,179 $2.8 Million
Q3 2019

Nov 12, 2019
BUY
$61.86 - $97.8 $45,034 - $71,198
728 Added 2.04%
36,472 $2.73 Million
Q2 2019

Aug 13, 2019
SELL
$42.22 - $63.23 $191,129 - $286,242
-4,527 Reduced 11.24%
35,744 $2.26 Million
Q1 2019

May 15, 2019
BUY
$31.96 - $56.12 $31,352 - $55,053
981 Added 2.5%
40,271 $1.94 Million
Q4 2018

Feb 14, 2019
SELL
$28.72 - $52.63 $218,185 - $399,830
-7,597 Reduced 16.2%
39,290 $1.32 Million
Q3 2018

Nov 14, 2018
SELL
$32.0 - $52.4 $22,240 - $36,418
-695 Reduced 1.46%
46,887 $2.46 Million
Q2 2018

Aug 13, 2018
SELL
$19.85 - $32.0 $28,981 - $46,720
-1,460 Reduced 2.98%
47,582 $1.49 Million
Q1 2018

May 14, 2018
SELL
$19.3 - $23.65 $148,146 - $181,537
-7,676 Reduced 13.53%
49,042 $1.07 Million
Q4 2017

Feb 14, 2018
BUY
$16.3 - $21.9 $42,706 - $57,377
2,620 Added 4.84%
56,718 $1.15 Million
Q3 2017

Nov 13, 2017
BUY
$18.05 - $21.75 $67,633 - $81,497
3,747 Added 7.44%
54,098 $1.07 Million
Q2 2017

Aug 11, 2017
BUY
N/A
50,351
50,351 $871,000

Others Institutions Holding NVCR

# of Institutions
291
Shares Held
74.8M
Call Options Held
1.26M
Put Options Held
247K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.19B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email